Determinants and outcome of amiodarone-associated thyroid dysfunction.

Area of Science:

• Cardiology
• Endocrinology
• Pharmacology

Background:

• Amiodarone is a widely used antiarrhythmic drug.
• Thyroid dysfunction is a known adverse effect of amiodarone therapy.
• Predicting and managing amiodarone-induced thyroid dysfunction (AITD) is clinically important.

Purpose of the Study:

• To identify predictors of amiodarone-associated thyrotoxicosis and hypothyroidism.
• To assess the treatment outcomes of AITD.
• To provide guidance for clinicians managing patients on amiodarone.

Main Methods:

• A cohort of 303 patients receiving amiodarone for cardiac arrhythmias was studied.
• Thyroid function tests were monitored every 6 months.
• Statistical analysis was performed to identify predictors and assess outcomes.

Main Results:

• The incidence of amiodarone-associated thyrotoxicosis was 1.9 per 100 person-years, and hypothyroidism was 1.1 per 100 person-years.
• Predictors for thyrotoxicosis included younger age (<62 years).
• Predictors for hypothyroidism included higher baseline TSH, lower left ventricular ejection fraction, and diabetes mellitus.
• Gender was not a predictor for AITD.
• 42% of patients with thyrotoxicosis experienced spontaneous normalization of thyroid function without amiodarone discontinuation.

Conclusions:

• Amiodarone-associated thyrotoxicosis is more common than hypothyroidism.
• Age, baseline TSH, LVEF, and diabetes are predictors for AITD.
• Discontinuing amiodarone did not significantly impact the time to normalization of thyroid function.